期刊文献+

FAS-1377基因多态与胃癌TNM分期的关系

THE ASSOCIATION BETWEEN FAS-1377 POLYMORPHISMS AND TNM STAGING OF GASTRIC CANCER
暂未订购
导出
摘要 目的研究FAS-1377基因多态与胃癌TNM分期的关系。方法采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析方法,检测120例胃癌患者的FAS-1377基因多态性,用Pearsonχ2检验法分析其基因多态性与胃癌TNM分期的关系。结果 FAS-1377基因多态频率分布:纯合野生型GG为7.4%(7/95)、杂合型GA为61.1%(58/95)、纯合突变型AA为31.5%(30/95)。胃癌患者FAS-1377基因型与TNM分期无统计学意义(P=0.274)。结论 FAS-1377基因多态与青海地区胃癌患者TNM分期无相关性。 Objective To investigate the correlation between FAS polymorphisms and TNM staging of gastric cancer. Methods The polymorphisms of FAS were detected by polymerase chain reaction - restriction fragment length polymorphisms assay (PCR -RFLP) in 120 gastric cancer patients ,Pearson X2 was applied to assess the association between the polymorphisms of FAS and TNM staging of gastric cancer. Results The frequency of FAS - 1377 gene polymorphism is that homozygous wild -type GG is 7.4 percent (7/95), heterozygous GA is 61.1 percent(58/95) and homozygous mutant AA is 31.5 percent(30/95). FAS- 1377 gene polymorphism of gastric cancer patients was not associated with clinical stage, (P = 0. 274). Conclusions FAS - 1377 may not be associated with TNM staging of gastric cancer.
出处 《青海医学院学报》 CAS 2010年第4期239-241,共3页 Journal of Qinghai Medical College
基金 青海大学中青年科研基金项目(2008-QY-10)资助
关键词 胃癌 凋亡基因 基因多态性 分期 Gastric cancer Apoptotic gene Gene polymorphisms Stage
  • 相关文献

参考文献1

二级参考文献18

  • 1章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 2林东昕,孙瞳.单体型在肿瘤研究中的应用与展望[J].中华肿瘤杂志,2005,27(5):257-259. 被引量:5
  • 3Humlg QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol, 1997, 34:577-582.
  • 4Sibley K, Rollinson S, Allan JM, et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res, 2003, 63:4327-4330.
  • 5Wu J, Metz C, Xu X, et al. A novel polymorphic CAAT/enhancerbinding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. Immunol, 2003, 170 : 132-138.
  • 6Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol, 2004, 103:304- 309.
  • 7Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst, 2004, 96:1030-1036.
  • 8Ju ST, Panka DJ, Cui H, et al. Fas( CD95 )/Fas L interactions required for programmed cell death after T-cell activation. Nature, 1995, 373:444-448.
  • 9Krammer PH. CD95's deadly mission in the immune system. Nature, 2000, 407:789-795.
  • 10Kim R, Emi M, Tanabe K, et al. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Cancer, 2004, 100: 2281- 2291.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部